Mirum Pharmaceuticals (NASDAQ: [[ticker:MIRM]]) has appointed Ed Tucker to serve as its chief medical officer. He was most recently the chief operating officer of AstraZeneca (NYSE: [[ticker:AZN]]) subsidiary Acerta Pharma. His experience also includes positions at Bayer, Janssen Pharmaceutica, and Genentech. Foster City, CA-based Mirum Pharma, which launched late last year, is developing drugs for liver diseases. In July, the company raised $75 million from its IPO.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
